Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era
- PMID: 26441939
- PMCID: PMC4585099
- DOI: 10.3389/fmicb.2015.01016
Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era
Abstract
Human Cytomegalovirus (CMV) is a well-recognized pathogen in the context of HIV infection, but since the roll out of ART, clinical and scientific interest in the problem of HIV/CMV coinfection has diminished. However, CMV remains a significant cofactor in HIV disease, with an influence on HIV acquisition, disease progression, morbidity, and mortality. Disease manifestations may be a result of direct interplay between the two viruses, or may arise as a secondary consequence of immune dysregulation and systemic inflammation. The problem is most relevant when the rates of coinfection are high, most notably in sub-Saharan Africa, and in children at risk of acquiring both infections early in life. Understanding the interplay between these viruses and developing strategies to diagnose, treat and prevent CMV should be a priority.
Keywords: CMV; HIV-1; antiretroviral therapy; coinfection; immune activation; pediatric infectious diseases; sub-Saharan Africa.
Figures



Similar articles
-
Review of cytomegalovirus coinfection in HIV-infected individuals in Africa.Rev Med Virol. 2017 Jan;27(1). doi: 10.1002/rmv.1907. Epub 2016 Oct 7. Rev Med Virol. 2017. PMID: 27714898 Review.
-
High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women.J Clin Virol. 2017 Nov;96:17-19. doi: 10.1016/j.jcv.2017.08.016. Epub 2017 Sep 5. J Clin Virol. 2017. PMID: 28918126
-
Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants.PLoS One. 2014 Dec 18;9(12):e114870. doi: 10.1371/journal.pone.0114870. eCollection 2014. PLoS One. 2014. PMID: 25522217 Free PMC article.
-
Clinical consequences of asymptomatic cytomegalovirus in treated human immunodeficency virus infection.Curr Opin HIV AIDS. 2021 May 1;16(3):168-176. doi: 10.1097/COH.0000000000000678. Curr Opin HIV AIDS. 2021. PMID: 33833209 Free PMC article. Review.
-
Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.Curr HIV/AIDS Rep. 2016 Feb;13(1):10-9. doi: 10.1007/s11904-016-0297-9. Curr HIV/AIDS Rep. 2016. PMID: 26810437 Free PMC article. Review.
Cited by
-
Clinical characteristics of pediatric patients hospitalized with community-acquired pneumonia and cytomegalovirus DNA detected in bronchoalveolar lavage fluid.Front Pediatr. 2024 Jul 24;12:1407174. doi: 10.3389/fped.2024.1407174. eCollection 2024. Front Pediatr. 2024. PMID: 39114856 Free PMC article.
-
Rescue of Pentamer-Null Strains of Human Cytomegalovirus in Epithelial Cells by Use of Histone Deacetylase Inhibitors Reveals an Additional Postentry Function for the Pentamer Complex.J Virol. 2022 Apr 27;96(8):e0003122. doi: 10.1128/jvi.00031-22. Epub 2022 Mar 28. J Virol. 2022. PMID: 35343807 Free PMC article.
-
Major TCR Repertoire Perturbation by Immunodominant HLA-B*44:03-Restricted CMV-Specific T Cells.Front Immunol. 2018 Nov 14;9:2539. doi: 10.3389/fimmu.2018.02539. eCollection 2018. Front Immunol. 2018. PMID: 30487790 Free PMC article.
-
Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.JCI Insight. 2019 Dec 5;4(23):e130090. doi: 10.1172/jci.insight.130090. JCI Insight. 2019. PMID: 31697647 Free PMC article.
-
Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.AIDS. 2017 Mar 27;31(6):807-813. doi: 10.1097/QAD.0000000000001412. AIDS. 2017. PMID: 28121712 Free PMC article.
References
-
- Alao O. O., Mamman A., Araoye M. O., Joseph E. (2009). Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria. Niger. Postgrad. Med. J. 16, 139–142. - PubMed
-
- Böhler T., Wintergerst U., Linde R., Belohradsky B. H., Debatin K. M. (2001). CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART). Pediatr. Res. 49, 101–110. 10.1203/00006450-200101000-00021 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources